Abstract
Distinct from previously reported urea and amide inhibitors of soluble epoxide hydrolase (sEH), a novel class of inhibitors were rationally designed based on the X-ray structure of this enzyme and known amide inhibitors. The structure-activity relationship (SAR) study was focused on improving the sEH inhibitory activity. Aminobenzisoxazoles emerged to be the optimal series, of which a potent human sEH inhibitor 7t was identified with a good pharmacokinetics (PK) profile. The strategy of employing aminoheterocycles as amide replacements may represent a general approach to develop mimics of known hydrolase or protease inhibitors containing an amide moiety.
MeSH terms
-
Amides / chemistry*
-
Aniline Compounds / chemical synthesis
-
Aniline Compounds / chemistry*
-
Aniline Compounds / pharmacokinetics
-
Animals
-
Binding Sites
-
Computer Simulation
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacokinetics
-
Epoxide Hydrolases / antagonists & inhibitors*
-
Epoxide Hydrolases / metabolism
-
Heterocyclic Compounds, 2-Ring / chemical synthesis
-
Heterocyclic Compounds, 2-Ring / chemistry*
-
Heterocyclic Compounds, 2-Ring / pharmacokinetics
-
Humans
-
Isoxazoles / chemical synthesis
-
Isoxazoles / chemistry*
-
Isoxazoles / pharmacokinetics
-
Protein Binding
-
Rats
-
Structure-Activity Relationship
Substances
-
Amides
-
Aniline Compounds
-
Enzyme Inhibitors
-
Heterocyclic Compounds, 2-Ring
-
Isoxazoles
-
Epoxide Hydrolases